Difference between revisions of "Plasminogen activator inhibitor-2"
(New page: {{subst:infobox}}) |
m |
||
| (3 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
| − | |||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
| − | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
| − | |||
| − | |||
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
| Line 9: | Line 6: | ||
|- | |- | ||
| Synonyms | | Synonyms | ||
| − | | | + | | Urokinase inhibitor |
|- | |- | ||
| Determination type | | Determination type | ||
| − | | In | + | | In vitro |
|- | |- | ||
| Source | | Source | ||
| Line 18: | Line 15: | ||
|- | |- | ||
| Subcellular localization | | Subcellular localization | ||
| − | | | + | | Cytosol |
| + | Plasma | ||
|- | |- | ||
| Swissprot ID | | Swissprot ID | ||
| − | | [http://au.expasy.org/uniprot/ | + | | [http://au.expasy.org/uniprot/P05120 P05120 ] |
|- | |- | ||
| Reactive glutamines | | Reactive glutamines | ||
| − | | | + | | Q83, Q84, Q86 |
|- | |- | ||
| Reactive lysines | | Reactive lysines | ||
| Line 30: | Line 28: | ||
|- | |- | ||
| Substrate sequence | | Substrate sequence | ||
| − | | | + | | SCGFM''QQ''I''Q''KGSYP |
|- | |- | ||
| Structure | | Structure | ||
| − | | [http://www.rcsb.org/pdb/explore/explore.do?structureId= | + | | [http://www.rcsb.org/pdb/explore/explore.do?structureId=1BY7 1BY7] |
|- | |- | ||
| Surface accessibility | | Surface accessibility | ||
| − | | | + | | |
|- | |- | ||
| Disorder prediction | | Disorder prediction | ||
| Line 42: | Line 40: | ||
|- | |- | ||
| Reference | | Reference | ||
| − | | [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids= | + | | [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=7910824&dopt=Abstract PMID:7910824] |
|- | |- | ||
| Notes | | Notes | ||
| − | | | + | | Polymerization occurs upon transglutaminase action |
| + | |||
| + | Crosslinking by TG2 has no effect on the protein's function/activity. | ||
|- | |- | ||
| − | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
[[Category:Tissue transglutaminase|*]] | [[Category:Tissue transglutaminase|*]] | ||
Latest revision as of 11:52, 10 March 2015
| Plasminogen activator inhibitor-2 | |
|---|---|
| Substrate peptide name | Plasminogen activator inhibitor-2 |
| Synonyms | Urokinase inhibitor |
| Determination type | In vitro |
| Source | Homo sapiens |
| Subcellular localization | Cytosol
Plasma |
| Swissprot ID | P05120 |
| Reactive glutamines | Q83, Q84, Q86 |
| Reactive lysines | Not determined yet |
| Substrate sequence | SCGFMQQIQKGSYP |
| Structure | 1BY7 |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:7910824 |
| Notes | Polymerization occurs upon transglutaminase action
Crosslinking by TG2 has no effect on the protein's function/activity. |
